ARTHROTEK TRIAL IN RHEUMATIC DISEASE

Authors
NASONOVA VA SIGIDIN YA MURAVYEV YV LEBEDEVA OI BURTSEV VI RASHUPKINA ZP KRIKUNOV VP KUZIN AV NASONOV YL CHICHASOVA NV
Citation
Va. Nasonova et al., ARTHROTEK TRIAL IN RHEUMATIC DISEASE, Terapevticeskij arhiv, 67(1), 1995, pp. 34-38
Citations number
NO
Categorie Soggetti
Medicine, General & Internal
Journal title
Terapevticeskij arhiv → ACNP
ISSN journal
00403660
Volume
67
Issue
1
Year of publication
1995
Pages
34 - 38
Database
ISI
SICI code
0040-3660(1995)67:1<34:ATIRD>2.0.ZU;2-D
Abstract
A clinical trial of arthrotek (Searle) in 60 RA patients aged 16-77 ye ars demonstrated its high antiinflammatory activity in 47 of them. The se patients have received a complete treatment course. 10 patients wer e not included in the overall estimations because of side affects (gas tric pains and nausea) causing them to withdraw early in the treatment course, 3 patients were nonresponders. The responders experienced att enuation of joint pain, morning stiffness. Inflammation in some joints declined, the articular index decrease.